Halozyme Therapeutics shares owned by Westover Capital Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Westover Capital Advisors
from 13F filings
Historical chart of Westover Capital Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Westover Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Westover Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-03-31 | $503k | 13k | 38.19 |
| 2022-12-31 | $760k | 13k | 56.90 |
| 2021-06-30 | $282k | 6.2k | 45.35 |